AD
Natalizumab(CAS: 189261-10-7)
CAS Number
Related Products
![ethyl 2-chloro-2-[(4-methoxyphenyl)hydrazono]acetate](https://static.chemtradehub.com/structs/271/27143-07-3-e25b.webp)
Bimatoprost acid methyl ester
CAS Number: 38315-47-8
![N-[(1R)-1-(Dihydroxyboryl)-3-methylbutyl]-Nalpha-(2-pyrazinylcarbonyl)-L-phenylalaninamide](https://static.chemtradehub.com/structs/179/179324-69-7-701f.webp)
![(2alpha,5beta,7alpha,10beta,13alpha)-4,10-Diacetoxy-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate](https://static.chemtradehub.com/structs/105/105454-04-4-0e99.webp)
(+)-Cloprostenol
CAS Number: 54276-21-0
![(3AS,4R,5S,6AR)-5-(Benzoyloxy)hexahydro-4-(hydroxymethyl)-2H-cyclopenta[B]furan-2-one](https://static.chemtradehub.com/structs/532/53275-53-9-7cca.webp)
![Pneumocandin A0, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]-](https://static.chemtradehub.com/structs/168/168110-44-9-d040.webp)
Sunitinib
CAS Number: 557795-19-4
Other Suppliers for Natalizumab
Basic Information
Molecular Formula
C46H80N14O16SSe
Molecular Weight
1196.26 g/mol
Chemical Identifiers
SMILES
CC[C@H](C)[C@@H](C(=N[C@@H](CC(C)C)C(=N[C@@H](C)C(=N[C@@H]([C@@H](C)O)C(=N[C@@H](C)C(=N[C@@H](CC(=N)O)C=O)O)O)O)O)O)NN[C@@H](CCC(=N)O)C(=N[C@@H](C[SeH])C(=O)C(=O)[C@H](CCSC)N=C([C@H](C)NN[C@@H](CC(=N)O)C(=O)O)O)O
InChIKey
UVWKUTFXSMNLGZ-IOVPNUEZSA-N
Database References
FAQ
Natalizumab (CAS: 189261-10-7) is a humanized monoclonal antibody used to treat multiple sclerosis and Crohn's disease. It targets the integrin receptor alpha 4, which is involved in the migration of immune cells across the blood-brain barrier and intestinal lining.
Natalizumab (CAS: 189261-10-7) is primarily used to treat relapsing forms of multiple sclerosis and active inflammatory Crohn's disease. It helps in reducing the frequency of relapses and maintaining remission in MS patients and improving symptoms and remission in Crohn's disease patients.
Natalizumab (CAS: 189261-10-7) is generally considered safe when used under medical supervision. However, it carries a risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. Patients must undergo regular monitoring for early signs of PML and other potential adverse effects.
Natalizumab (CAS: 189261-10-7) should be stored at 2-8°C (36-46°F) in its original vial. It should be kept away from direct light and protected from extreme temperatures. Do not freeze the product, and discard any unused portion that has been thawed or exposed to temperatures above 25°C (77°F).
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Huimei
sales@kedechemical.com
Mobile
13093829633
Telephone
0576-84613060
Visit Website
https://www.kedechemical.comAddress
No. 411 Jusong Avenue, Dongmao Building, Huangyan District, Taizhou City, Zhejiang Province